Techspective
Neuralink security “has to be solid” to avoid brain hacking
Verdict
Oliver Tavakoli, chief technology officer at cybersecurity firm Vectra, compares Neuralink’s potential to change our bodies to gene-editing tool CRISPR, in that both “can be good and for evil”.